GZD824 Dimesylate
GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl (WT) and Bcr-Abl (T315I) .
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
724.77
Molecular Formula
C29H27F3N6O·2CH4O3S
Notes
Research use only, not for human use.
Receptor
Abl| Abl (E255K) | Abl (H396P) | Abl (M351T) | Abl (Q252H)
CAS Number
1421783-64-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ARP72178_P050-FITC 100 µL
CT47A12 Antibody - C-terminal region: FITC (ARP72178_P050-FITC)
Ask
View Details 
MBS9326599-01 48 Well
Mouse Ubiquitin carboxyl-terminal hydrolase CYLD, CYLD ELISA Kit
Ask
View Details MBS9326599-02 96 Well
Mouse Ubiquitin carboxyl-terminal hydrolase CYLD, CYLD ELISA Kit
Ask
View Details